Barclays analyst Jiong Shao maintains Trip.com Group (NASDAQ:TCOM) with a Overweight and raises the price target from $33 to $35.
Elevation Oncology Q3 EPS $(1.67) Down From $(0.53) YoY
Elevation Oncology (NASDAQ:ELEV) reported quarterly losses of $(1.67) per share. This is a 215.09 percent decrease over losses of $(0.53) per share from the same period last year.